2000 SIERRA POINT PARKWAY, BRISBANE, CA
Market cap: $11.9M (2/09/2026)
Price: $2.42
Investor Presentation
Tempest Therapeutics Acquires CAR T-Cell Therapy Assets from Erigen LLC
Material disclosure
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Annual Report to Security Holders
Announces Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
Asset Purchase Agreement with Erigen LLC and Factor Bioscience Inc.
Reports Third Quarter 2025 Financial Results and Provides Business Update
Q3
Q2
Q1
FY 2024
FY 2023
Effectiveness Notice
S-1
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Schedule 13G - Ownership Report
S-8 POS
Correspondence